Potent antiplatelet drugs increase major bleeding risk in AF patients after heart attack

Potent antiplatelet therapy accrued bleeding without signs of payment regarding cardiovascular events successful patients with atrial fibrillation aft a bosom attack. This was the main uncovering of the EPIDAURUS proceedings presented successful a Hot Line league astatine ESC Congress 2026 and published simultaneously successful Nature Medicine.